摘要
福莫特罗(FMT)是新型长效β2受体选择性激动药,对β2受体的选择性和内在活性比沙丁胺醇和间羟舒喘宁高,其气道扩张作用以及对组胺、乙酰甲胆碱等引起的气道收缩的抑制作用可达12h以上。此外,它还有较强的抗炎作用。适用于慢性哮喘、夜间哮喘、EIA和COPD等,是一种长效高活性的平喘新药。
Formoterol is a long-acting β2-receptor agonist. Its selectivity for β2-receptor and intrinsic activity are higher than those of salbutamol and terbutaline. Its bronchodilating action and protecting effect against bronchoconstriction caused by his-tamine or methacholine can last more than 12 hours; It also has a singnificant anti-in-flamlnatory effect.Formoterol is an effective therapeutic drug for chronic bronchial asthrna,nocturnal asthma,exercise-induced asthma and chronic obstructive pulmonary diseases.
出处
《中国新药杂志》
CAS
CSCD
1994年第4期14-17,共4页
Chinese Journal of New Drugs